Experimental autoimmune uveitis (EAU) induced by the interphotoreceptor retinoid-binding protein (IRBP), which shares many pathological characteristics with those of human uveitis, is widely used to help illuminate the genetic influences on, resolve the pathogenic mechanisms of, and test potential therapeutic paradigms for human uveitis since 1988 [7–9]. This evidence concerns the gene RBP3 and uveitis.